M&A activity in the pharma sector decreases in both volume and value terms
The pharma sector recorded 27 M&A transactions in July 2012, against the previous six months’ average of 49 transactions
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Pharmexcil and MHLW, Japan to promote generic drugs
Invites Indian pharma players to supply drugs at affordable price
CDSCO calls for suggestions on draft guidelines for compensating clinical trial victims
Recommendations to be submitted before September 2, 2012
Commerce Ministry to discuss issues on non-tariff barriers in pharma industry with US and EU
Pharma industry to form committee of all industry representatives
Q1 results registers ups and downs in Indian pharma sector
Indian pharma companies have recently released Q1 results, Express Pharma highlights the Q1 performance
Pharmexcil’s India Pavilion at CphI Worldwide 2012 to project Indias pharma sector to new…
The 23rd edition of CPhI Worldwide 2012 to see participation from 140 countries
Improving access, innovation, reach key to achieving UHC
Putting Universal Healthcare (UHC) at the top of the agenda, OPPI’s recent conclave on ‘Improving Access, Innovation and Reach of…
Trends Exports organises seminar on EU-GMP inspection
Trends Exports recently organised a seminar in Mumbai for understanding regulatory aspects of EU-GMP inspection in Europe.
Indegene introduces TrialPedia 2.0 with ‘Advantage Insights’
Clients can enhance the business value of clinical trial analytics with over 180,000+ trials across 200+ indications updated in…